Mohannad B. Bisharat

Cardiology
3900 University Blvd S
Jacksonville, FL 32216

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Clinical Pharmacokinetics and Pharmacodynamics of Baxdrostat.

Clinical Pharmacokinetics and Pharmacodynamics of Baxdrostat.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: December 05, 2024

Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE-CVD Study).

Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE-CVD Study).

Journal: Clinical cardiology
Published: June 05, 2024

A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device for the Treatment of Pulmonary Embolism (ENGULF).

A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device for the Treatment of Pulmonary Embolism (ENGULF).

Journal: Journal of the Society for Cardiovascular Angiography & Interventions
Published: March 06, 2024

One-Year Clinical Outcomes Following Mechanical Thrombectomy for Deep Vein Thrombosis: A CLOUT Registry Analysis.

One-Year Clinical Outcomes Following Mechanical Thrombectomy for Deep Vein Thrombosis: A CLOUT Registry Analysis.

Journal: Journal of the Society for Cardiovascular Angiography & Interventions
Published: September 28, 2023

Mechanical Thrombectomy for High-Risk Pulmonary Embolism: Insights From the US Cohort of the FLASH Registry.

Mechanical Thrombectomy for High-Risk Pulmonary Embolism: Insights From the US Cohort of the FLASH Registry.

Journal: Journal of the Society for Cardiovascular Angiography & Interventions
Published: May 12, 2023

A Critical Review of Icosapent Ethyl in Cardiovascular Risk Reduction.

A Critical Review of Icosapent Ethyl in Cardiovascular Risk Reduction.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: April 05, 2023

Longer-Term Outcomes Following Mechanical Thrombectomy for Intermediate- and High-Risk Pulmonary Embolism: 6-Month FLASH Registry Results.

Longer-Term Outcomes Following Mechanical Thrombectomy for Intermediate- and High-Risk Pulmonary Embolism: 6-Month FLASH Registry Results.

Journal: Journal of the Society for Cardiovascular Angiography & Interventions
Published: March 29, 2023

Six-Month Outcomes of Mechanical Thrombectomy for Treating Deep Vein Thrombosis: Analysis from the 500-Patient CLOUT Registry.

Six-Month Outcomes of Mechanical Thrombectomy for Treating Deep Vein Thrombosis: Analysis from the 500-Patient CLOUT Registry.

Journal: Cardiovascular and interventional radiology
Published: March 29, 2023

Safety and Effectiveness of Mechanical Thrombectomy From the Fully Enrolled Multicenter, Prospective CLOUT Registry.

Safety and Effectiveness of Mechanical Thrombectomy From the Fully Enrolled Multicenter, Prospective CLOUT Registry.

Journal: Journal of the Society for Cardiovascular Angiography & Interventions
Published: October 25, 2022

Correction to: A Review of the Clinical Pharmacology of Pelacarsen: A Lipoprotein(a)-Lowering Agent.

Correction to: A Review of the Clinical Pharmacology of Pelacarsen: A Lipoprotein(a)-Lowering Agent.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: December 11, 2021

Interim outcomes of mechanical thrombectomy for deep vein thrombosis from the All-Comer CLOUT Registry.

Interim outcomes of mechanical thrombectomy for deep vein thrombosis from the All-Comer CLOUT Registry.

Journal: Journal of vascular surgery. Venous and lymphatic disorders
Published: November 01, 2021

A Review of the Clinical Pharmacology of Pelacarsen: A Lipoprotein(a)-Lowering Agent.

A Review of the Clinical Pharmacology of Pelacarsen: A Lipoprotein(a)-Lowering Agent.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: August 11, 2021
Showing 1-12 of 17

Last Updated: 09/26/2026